In this article, we will delve into the Transgene Biotek Share Price Targets for 2023, 2024, 2025, 2028, and 2030 . As a company specializing in the Research & Development of Pharmaceutical products, Transgene Biotek has gained attention from investors and stakeholders alike. We will explore the company’s profile, product offerings, and its share price history. Furthermore, we will provide insights into the projected share price targets for the years 2023, 2024, 2025, 2028, and 2030, based on the available data and market analysis provided by BazarProfit Team.
Transgene Biotek Company Profile
Transgene Biotek Limited, established in 1990, is a leading player in the pharmaceutical industry, primarily focusing on the production and oral formulation of various proteins using their innovative TrabiORAL technology. The company’s registered office is situated in Telangana, India. Transgene Biotek has expertise in multiple areas, including oncology, autoimmunity, drug delivery, and biogenerics.
Read More: Evexia Lifecare Share Price Targets 2024, 2025
Transgene Biotek Products
The company boasts an extensive product portfolio that includes several noteworthy offerings:
- TrabiDHA™ 40 (40% DHA Oil)
- TrabiDHA™ 50 (50% DHA Oil)
- TrabiDHA™ P10 (10% DHA Powder)
- TrabiDHA™ P20 (20% DHA Powder)
- TrabiDHA™ Capsules
Fundamental Analysis of Transgene Biotek Ltd
Before making investment decisions, it is crucial to conduct a fundamental analysis of the company to assess its financial health and potential for growth. Let’s take a closer look at Transgene Biotek Ltd’s fundamental metrics in the table below:
| Metric | Value |
|---|---|
| Market Cap | ₹ 27.9 Cr. |
| Current Price | ₹ 3.68 |
| High / Low | ₹ 5.09 / ₹ 2.28 |
| Stock P/E | – |
| Book Value | ₹ 1.50 |
| Dividend Yield | 0.00 % |
| ROCE | -21.6 % |
| ROE | -41.8 % |
| Face Value | ₹ 10.0 |
| Profit after tax | ₹ -6.01 Cr. |
| Profit growth | 42.2 % |
| Sales growth | -33.3 % |
| Industry PE | 34.8 |
| Pledged percentage | 0.00 % |
| Earnings yield | -13.9 % |
| Promoter holding | 23.6 % |
| Net worth | ₹ 11.4 Cr. |
| Debt | ₹ 13.1 Cr. |
| Qtr Sales Var | -100 % |
| Return over 1 year | 13.1 % |
| Return over 3 years | -7.70 % |
| Return over 5 years | 13.3 % |
| Sales growth 3 years | -% |
| Sales growth 5 years | -12.9 % |
| Profit Var 3 Years | 13.2 % |
| Reserves | ₹ -64.4 Cr. |
| Debt to equity | 1.15 |
The fundamental analysis of Transgene Biotek Ltd provides valuable insights into the company’s financial performance and position. The company is currently facing challenges with declining sales, negative earnings yield, and ROCE and ROE in negative territory. However, there are positive aspects to consider, such as profit growth and a relatively low industry PE ratio. As an investor, it is essential to carefully assess these fundamental metrics along with the projected share price targets and perform further research before making any investment decisions. Investing in the stock market carries inherent risks, and it is advisable to seek professional financial advice before making investment choices.
Read More: TATA STEEL SHARE PRICE TARGET
Transgene Share Price
Before we delve into the future share price targets, let’s briefly review the stock’s performance in recent times.
As of the latest data available, the Transgene Biotek Ltd stock is currently trading at 3.79 Rs. Over the last five days, the stock has experienced a return of -3.56%, while the one-month return stands at -12.87%. However, investors should note that past performance does not guarantee future results.
Transgene Biotek Share Price Target 2023
In the year 2023, as per the analysis provided by BazarProfit Team, Transgene Biotek’s share price may reach a high of 5.21 Rs and a low of 0.31 Rs. The predicted price range indicates potential growth opportunities, and investors should closely monitor the company’s performance and market trends.
Transgene Biotek Share Price Target 2024
Looking ahead to 2024, BazarProfit Team projects that the share price of Transgene Biotek could reach a maximum of 5.21 Rs and a minimum of 3.11 Rs. These estimates are based on a variety of factors, including the company’s financial performance, industry trends, and macroeconomic conditions.
Transgene Biotek Share Price Target 2025
For the year 2025, as analyzed by BazarProfit Team, experts predict a potential price range of a maximum of 5.89 Rs and a minimum of 4.14 Rs. Investors should be aware that these projections are subject to change based on various market dynamics and the company’s strategic decisions.
Transgene Biotek Share Price Target 2028
Taking a more extended view, BazarProfit Team expects the share price target for 2028 to remain consistent with the price range of 5.89 Rs as the maximum and 4.14 Rs as the minimum. These predictions assume steady growth and sustained business performance over the years.
Transgene Biotek Share Price Target 2030
By the year 2030, BazarProfit Team foresees an optimistic outlook for Transgene Biotek’s share price. The projected maximum stands at an impressive 12.73 Rs, while the minimum is estimated to be 7.884 Rs. These figures reflect the potential growth opportunities and the company’s ability to capitalize on its products and technologies.
Conclusion
Transgene Biotek Ltd, with its focus on pharmaceutical research and development, presents an intriguing investment opportunity for investors. However, as with any investment, it is essential to conduct thorough research and consider various factors before making decisions. The projected share price targets provided here, based on the analysis by BazarProfit Team, are valuable insights for investors. Always remember that investing in the stock market carries inherent risks, and past performance may not accurately predict future results.
5 thoughts on “Transgene Biotek Share Price Target -2023, 2024, 2025, 2028, and 2030”